

Author: Sibley Christopher D Rabin Harvey Surette Michael G
Publisher: Future Medicine
ISSN: 1746-0913
Source: Future Microbiology, Vol.1, Iss.1, 2006-06, pp. : 53-61
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Cystic fibrosis (CF) is the most common lethal genetic disease in the Caucasian population, and should be considered an infectious disease because of the basic pathophysiology. Chronic lower airway infections cause a progressive pathologic deterioration of lung tissue, a decline in pulmonary function and, ultimately, respiratory failure and death in 90% of CF patients. Historically, very few bacterial species have been implicated as principal CF pathogens. However, molecular evidence suggests the presence of a diverse mosaic of bacteria in CF lungs, and infections can be defined as polymicrobial. Here we review the work that supports this concept and we discuss the potential significance of the polymicrobial community in lung pathology. Understanding the dynamics of polymicrobial infections, the interplay between pathogen(s), normal oropharyngeal flora and the host immune system may lead to future advances in the therapeutic management of chronic lung infections.
Related content






By Gaspar M. Couet W. Olivier J.-C. Pais A. Sousa J.
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 32, Iss. 10, 2013-10 ,pp. :




Cystic fibrosis pathogenesis and the role of biofilms in persistent infection
Trends in Microbiology, Vol. 9, Iss. 2, 2001-02 ,pp. :